Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00053014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
ClinicalTrials.gov study NCT02071901. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image
ClinicalTrials.gov study NCT00172562. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06773208. IPD Sharing: YES. Countries: 1. Publications: 0.
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04215822. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03813147. IPD Sharing: YES. Countries: 1. Publications: 0.
Frequency and Risk Factors of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05787951. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment
ClinicalTrials.gov study NCT05628623. IPD Sharing: NO. Countries: 0. Publications: 21.
Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00766116. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) i
ClinicalTrials.gov study NCT05197426. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Transfusion in Adult Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02899767. IPD Sharing: Not stated. Countries: 0. Publications: 1.
AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00071006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01806571. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00899171. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission
ClinicalTrials.gov study NCT02302846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT03399773. IPD Sharing: NO. Countries: 1. Publications: 0.
MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00462605. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
ClinicalTrials.gov study NCT02038153. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy
ClinicalTrials.gov study NCT02089230. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00899743. IPD Sharing: Not stated. Countries: 0. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.